Protected: NEW HOPE FOR CHRONIC PAIN: DR. RONALD SEGURA IMPLANTS THE FIRST BIOTRONIK PROSPERA SCS IN LOUISIANA HOSPITAL
FOR IMMEDIATE RELEASE – May 29, 2025
Media Inquiries: Brooke Russell | 985.801.6212 | info@avala.com
Covington, Louisiana—Dr. Ronald Segura, with Segura Neuroscience and Pain Center operating at AVALA, implanted the first-ever BIOTRONIK Prospera™ spinal cord stimulator in a Louisiana hospital. This procedure marks a notable step forward in offering patients innovative solutions for intractable pain conditions.
The Prospera™ SCS System is distinguished by its incorporation of RESONANCE™, a proprietary multiphase stimulation paradigm. This technology is designed to deliver electrical pulses to the spinal cord, aiming to modulate pain signals before they reach the brain. Additionally, the system features Embrace One™, a proactive care model that enables automatic, objective, daily remote monitoring of the device and therapy. This approach facilitates continuous optimization of the therapy over time.
Clinical Implications and Considerations
Clinical studies, such as the BENEFIT-02 trial, have explored the efficacy of the RESONANCE™ stimulation paradigm. Preliminary findings suggest that this approach may offer significant pain relief for patients with chronic conditions. However, as with any emerging medical technology, it’s essential to approach these results with cautious optimism. Long-term studies and broader patient populations are necessary to fully understand the benefits and potential limitations of the Prospera™ system.
Dr. Segura’s Role in Advancing Pain Management
Dr. Ronald C. Segura, a board-certified specialist in Physical Medicine and Rehabilitation and Interventional Pain Medicine, has been at the forefront of adopting advanced pain management techniques in Louisiana. His decision to implement the Prospera™ SCS System reflects a commitment to exploring innovative therapies for patients with chronic pain. While this procedure represents a promising development, ongoing evaluation and patient monitoring will be crucial to assess its long-term effectiveness and safety.
“The BIOTRONIK Prospera™ SCS System is a game-changer for patients living with chronic pain. What sets it apart is the ability to continuously monitor and optimize therapy in real-time, which means we can provide more precise, responsive care. It’s a major leap forward—not just in technology, but in how we’re able to improve quality of life for our patients,” said Dr. Ronald Segura, Pain Management Specialist.
For more information about the BIOTRONIK Prospera™ spinal cord stimulator and how it could benefit you, contact AVALA’s Patient Navigator at 985.801.6214 or request an appointment below.
